JBJ-04-125-02
- CAS No.
- 2060610-53-7
- Chemical Name:
- JBJ-04-125-02
- Synonyms
- JBJ-04-125-02 R-isomer;JBJ0412502,JBJ 04 125 02;(R)-2-(5-Fluoro-2-hydroxyphenyl)-2-(1-oxo-6-(4-(piperazin-1-yl)phenyl)isoindolin-2-yl)-N-(thiazol-2-yl)acetamide;2H-Isoindole-2-acetamide, α-(5-fluoro-2-hydroxyphenyl)-1,3-dihydro-1-oxo-6-[4-(1-piperazinyl)phenyl]-N-2-thiazolyl-, (αR)-;(2R)-2-(5-Fluoro-2-hydroxyphenyl)-2-{1-oxo-6-[4-(piperazin-1-yl)phenyl]-1,3-dihydro-2H-isoindol-2-yl}-N-(1,3-thiazol-2-yl)acetamide
- CBNumber:
- CB46199845
- Molecular Formula:
- C29H26FN5O3S
- Molecular Weight:
- 543.62
- MDL Number:
- MFCD33029239
- MOL File:
- 2060610-53-7.mol
| Product description | Number | Pack Size | Price |
| JBJ-04-125-02 | CS-0114212 | 5mg | $600 |
| JBJ-04-125-02 | CS-0114212 | 10mg | $880 |
| JBJ-04-125-02 | CS-0114212 | 50mg | $2350 |
| JBJ-04-125-02 | CS-0114212 | 100mg | $3800 |
JBJ-04-125-02 price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0114212 | JBJ-04-125-02 | 2060610-53-7 | 5mg | $600 | 2021-12-16 | Buy |
| ChemScene | CS-0114212 | JBJ-04-125-02 | 2060610-53-7 | 10mg | $880 | 2021-12-16 | Buy |
| ChemScene | CS-0114212 | JBJ-04-125-02 | 2060610-53-7 | 50mg | $2350 | 2021-12-16 | Buy |
| ChemScene | CS-0114212 | JBJ-04-125-02 | 2060610-53-7 | 100mg | $3800 | 2021-12-16 | Buy |
JBJ-04-125-02 Chemical Properties,Uses,Production
Uses
JBJ-04-125-02 is a potent, mutant-selective, allosteric and orally active EGFR inhibitor with an IC50 of 0.26 nM for EGFRL858R/T790M. JBJ-04-125-02 can inhibit cancer cell proliferation and EGFRL858R/T790M/C797S signaling. JBJ-04-125-02 has anti-tumor activities[1].
in vivo
JBJ-04-125-02 (50 mg/kg; oral gavage; once daily; for 15 weeks; EGFRL858R/T790M/C797S genetically engineered mice) treatment leads to marked tumor regressions within 4 weeks of treatment[1].
JBJ-04-125-02 exhibits a moderate half-life of 3 hours and a high area under curve of 728,577 min?ng/mL (AUClast) following 3 mg/kg intravenous (i.v.) dose. A 20 mg/kg oral dose of JBJ-04-125-02 achieves an average maximal plasma concentration of 1.1 μmol/L with an oral bioavailability of 3%[1].
| Animal Model: | EGFRL858R/T790M/C797S genetically engineered mice (GEM)[1] |
| Dosage: | 50 mg/kg |
| Administration: | Oral gavage; once daily; for 15 weeks |
| Result: | Led to marked tumor regressions within 4 weeks of treatment. |
IC 50
EGFR (L858R/T790M): 0.26 nM (IC50)
References
[1] To C, et al. Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor. Cancer Discov. 2019 Jul;9(7):926-943. DOI:10.1158/2159-8290.CD-18-0903
JBJ-04-125-02 Preparation Products And Raw materials
Raw materials
Preparation Products
JBJ-04-125-02 Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32435 | 58 |
| Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 | sales@sarms4muscle.com | China | 10473 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6391 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; | support@targetmol.com | United States | 39035 | 58 |
| TargetMol Chemicals Inc. | +17819995354 | marketing@targetmol.com | United States | 19962 | 58 |
| ShangHai Caerulum Pharma Discovery Co., Ltd. | 18149758185 | sales-cpd@caerulumpharma.com | China | 3506 | 58 |
| ShangHai Angti Biotechnology Co., Ltd. | 13764913901 | info@angtibio.com | China | 4986 | 55 |
| Changzhou Chenhong Biotechnology Co., Ltd. | +86-0519-85788828 +86-13775037613 | sales@chemrenpharm.com | China | 3934 | 58 |
| Chengdu Peter-like Biotechnology Co., Ltd. | 18108052721 | 2850505130@qq.com | China | 5167 | 58 |
| ShangHai ChuanQian Chemcial Technique Centre | 15869524721 | 3525679403@qq.com | China | 4989 | 58 |
View Lastest Price from JBJ-04-125-02 manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2025-10-27 | JBJ-04-125-02
2060610-53-7
|
US $2500.00-1520.00 / mg | 10g | TargetMol Chemicals Inc. | |||
![]() |
2025-08-22 | JBJ-04-125-02
2060610-53-7
|
US $2500.00-1520.00 / mg | 10g | TargetMol Chemicals Inc. |
-

- JBJ-04-125-02
2060610-53-7
- US $2500.00-1520.00 / mg
- TargetMol Chemicals Inc.
-

- JBJ-04-125-02
2060610-53-7
- US $2500.00-1520.00 / mg
- TargetMol Chemicals Inc.




